Filter
914
Text search:
drug-resistance
infections
Featured
114
260
Language
Document type
519
148
143
39
25
17
12
6
3
1
Countries / Regions
53
31
29
25
23
23
19
18
17
17
17
16
14
14
13
11
11
10
10
10
9
9
9
9
8
7
7
6
6
6
6
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
353
84
27
19
16
13
10
Toolboxes
192
142
125
39
36
16
12
9
8
8
8
8
7
5
4
4
3
3
3
2
2
1
1
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection.
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Supplement to the Healthcare Waste Management Toolkit for Global Fund
Practitioners and Policy Makers
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent
...
The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.
This guidance provides an overview of interventions to improve early diagnosis of TB and treatment completion in these populations, as well as factors to consider when developing programmes for health communication, awareness and education, and programme monitoring and evaluation
SOP- Quality Assurance of Malaria Diagnostic Tests
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
